Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients (MS).

NCT02142764 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT02142764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02142764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients (MS).
Lead sponsor
University Hospital, Bordeaux
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2014
Completion date
February 29, 2016
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis